Short acting beta2 agonists, bronchodilators such as Albuterol, Levalbuterol, and Pirbuterol, used in treating acute bronchoconstriction
SABA mechanism of action
They work by stimulating beta 2 receptors in the lungs, which results in bronchodilation
Even though they are inhaled, some systemic effects occur
Systemic effects of SABA
Cardiovascular: tachycardia, palpitations
CNS: excitation, nervousness, irritability
Skeletomuscular: Tremors
SABA indication
Indicated for both children and adults, albuterol is first-line therapy for acute asthma attacks
Montelukast
Leukotriene inhibitor, used in long-term treatment of disorders causing bronchoconstriction
Montelukast contains phenylalanine and so are contraindicated in patients with PKU
Adverse effects of montelukast
GI upset
Myalgia
Fever
CNS excitation including sleep disorders, restlessness, and irritability
Montelukast indication
The only leukotriene inhibitor that is indicated for children older than 1 year
Patient teaching for montelukast
Take as prescribed even if symptom free
Emphasis should be made that it is not for acute attacks
Zafirlukast is taken on an empty stomach
Made aware of CNS events such as agitation, anxiousness, insomnia
Self-monitor respiratory system, avoid or quick smoking, avoid triggers
Patient teaching for inhaled corticosteroids
Rinse mouth to prevent oral candidiasis
Tachycardia can occur
Bronchospasm can occur
Teach how to use, spacers can be used to get the most effect especially in children
Don't take the capsules by mouth they must be broken in the mechanism and inhaled
Not for use in acute asthma attack
Albuterol mechanism of action
Albuterol is a short acting beta 2 agonist, triggers beta 2 adrenergic receptors which results in direct bronchodilation
Inhaled corticosteroids mechanism of action
Corticosteroids suppress IgE immunoglobulins which are the main trigger for release of mast cells and other inflammatory factors
Adverse effects of inhaled corticosteroids are related to localized immunosuppression. Oral candidiasis can occur if the patient does not rinse after each use
When to use a short acting beta agonist
In the event of acute asthma attack. Albuterol is the first-line therapy and is indicated in children and adults
Inhaled muscarinic receptor antagonists mechanism of action
Muscarinic receptor antagonists are anticholinergics that work by competitively inhibiting cholinergic receptors, relieving bronchoconstriction by relaxing smooth muscle of the respiratory tract, and decreasing secretions
Anticholinergics, even inhaled can cause systemic effects
Inhaled anticholinergics
Ipatropium, tiotropium
Adverse effects of inhaled corticosteroids
Immunosuppression which can increase risk of oral candidiasis
Intranasal can cause nasal dryness, bloody nose, or itching
LABA
Long acting beta 2 adrenergic agonists used in the treatment of long-term COPD or other bronchoconstricting disease process
LABA/LAMA combination
Used as a first-line therapy in the treatment of COPD
LABA/LAMA combination
Salmeterol/ipratropium
Omalizumab mechanism of action and indication
Omalizumab is a monoclonal antibody that works by binding to free IgE which downregulates mast cells and basophils
Populations that should not be prescribed pseudoephedrine
Concurrent MAOI therapy
Severe HTN or coronary artery disease
Infants
Drug for nasal congestion with hypertension
Fluticasone OTC should be used. Pseudoephedrine can exacerbate HTN
Adverse effects of antihistamines
Drowsiness and dizziness related to antihistamine effect
1st gen can cause some anticholinergic effects such as dry mouth, and urinary retention
Conditions that should cause a patient to avoid antihistamines
Lower respiratory tract diseases due to thickened secretions
Narrow-angle glaucoma
Urinary constriction diseases
Antitussives and their mechanisms of action
Dextromethorphan: Elevates the threshold of coughing in the CNS
Codeine: Blocks cough receptors in the CNS
Benzonatate: Anesthetizes stretch receptors that cause coughing in the respiratory tract
Treatment of upper respiratory infections
Viral URI: Symptom management, decongestants
Sudafed contraindicated in children under 4
Tylenol, ibuprofen for general malaise
Bacterial URI: Add antibiotics to therapy regimen
Factors to consider when choosing a diuretic for hypertension
Set an appropriate goal
Thiazide diuretic is first-line for essential hypertension, hydrochlorothiazide is treatment of choice in uncomplicated patients
Loop diuretics may be appropriate in patients with altered kidney function
Thiazide diuretics do not work effectively in patients with kidney impairment
If a loop diuretic is prescribed then potassium must also be prescribed
Mechanisms of action of diuretic classes
Loop diuretics: Decrease sodium reabsorption in the ascending loop, increase sodium in the ascending loop results in water being pulled from the interstitial fluid and excreted through the urine, potassium is also excreted
Thiazide diuretics: Decrease sodium reabsorption in the descending loop
Potassium-sparing diuretics: Spare potassium by adding aldosterone
Patient education for taking antacids
Only take as prescribed, take 1-3 hours after a meal for best effect
If taking OTC only take as instructed
Separate antacids with other drugs by at least 1 hour
Constipation with Al and Ca based antacids
Diarrhea with Mg based antacids
Use low sodium preparations for those with HTN or other disease that requires low sodium
Take half glass of water after
Loperamide mechanism of action
Binds to opiate receptors in the intestinal wall to decrease peristalsis and secretions, an antidiarrheal
Lab values to monitor with long-term PPI administration
Vitamin B-12 deficiency
Fe deficiency
Ca deficiency
PPIs can cause vitamin B-12 deficiency in long-term use. Ca and Fe deficiency are not of clinical significance
Reason for osteoporosis risk with omeprazole
PPIs increase gastric pH which may reduce absorption of certain nutrients that are generally absorbed in the stomach
Most rapid acting laxative
Stimulants such as bisacodyl directly stimulate peristalsis causing the intestines to move fecal matter out. Osmotic laxatives like PEG 3350 are also very fast
How metoclopramide improves GERD
Metoclopramide is a prokinetic that increases gastric motility and tone, improving symptoms of GERD by increasing gastric motility and esophageal sphincter tone
Limitations of metoclopramide use for GERD
Only used for GERD that is not able to be treated by PPI or H2RA
Has significant side effects, EPS, depression
Only indicated in patients who have delayed gastric emptying that do not respond to other treatments
Symptoms of GERD are associated with gastric acid getting into the esophagus due to a weak esophageal sphincter and decreased gastric pH
Step Down Approach with GERD
Start with high dose PPI and antacids and slowly work down to a dose that decreases symptoms
Usual duration of therapy is 8 weeks before tapering starts
If it does not work then increase to 2 times a day for 8 weeks
Step-down is indicated in patients who have moderate to severe symptoms and will provide quick relief
PPIs, short-term, have minimal adverse effects so a step-down approach is not necessarily more risky than a step-up